Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Venous Engorgement as a Pitfall: Postpartum Intracranial Hypotension Mimicking Pituitary Mass

Author:Marcell, Shawn   Pham, Anthony   Patel, Nina   Copeland, Brian   El-Abassi, Rima   

Session Name:P6: Headache: Low and High CSF Pressure Headaches  

Topic:Headache  

Program Number:P6.011  

Author Institution:LSUHSC New Orleans Department of Neurology, New Orleans, LA  LSUHSC New Orleans School of Medicine, New Orleans, LA  

Temporary Occipital Nerve Stimulation as Transitional Therapy for Chronic Intractable Cluster Headache: A Case Report and Proof of Concept

Author:Pardo, Keshet   Boes, Christopher   Kissoon, Narayan   

Session Name:P6: Headache: Cluster, Trigeminal Neuralgia, and Other Trigeminal Pain  

Topic:Headache  

Program Number:P6.015  

Author Institution:Department of Neurology, Mayo Clinic, Rochester, MN, Rochester, MN  

A Study of NE3107 (Bezisterim) in Early Parkinson’s Disease (SUNRISE-PD): Baseline Demographics and Characteristics

Author:Palumbo, Joseph   Ahlem, Clarence   Reading, Chris   Zhang, Jeffrey   Stacy, Mark   

Session Name:P6: Movement Disorders: Parkinson's Disease Emerging Therapeutics 1  

Topic:Movement Disorders  

Program Number:P6.017  

Author Institution:BioVie Inc., Carson City, NV  Princeton Pharmatech LLC., Princeton, NJ  MUSC Department of Neurology, Charleston, SC  

Subgroup Analyses of the Phase Three Tolebrutinib in Non-relapsing Secondary Progressive Multiple Sclerosis (nrSPMS) HERCULES Trial

Author:Fox, Robert J.   Bar-Or, Amit   Traboulsee, Anthony   Oreja-Guevara, Celia   Giovannoni, Gavin   Vermersch, Patrick   Syed, Sana   Li, Ye   Vargas, Wendy S.   Turner, Timothy J.   Wallstroem, Erik   Reich, Daniel S.   

Session Name:P7: Multiple Sclerosis: Clinical Trials 1  

Topic:Multiple Sclerosis  

Program Number:P7.004  

Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States, OH  Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, University of Pennsylvania, Philadelphia, United States, PA  The University of British Columbia, Division of Neurology, Vancouver, Canada, BC, Canada  Departamento de Neurologia, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain  Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain, Spain  Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, United Kingdom  University of Lille, Inserm U1172, CHU Lille, FHU Precise, Lille, France, France  Sanofi, Cambridge, United States, MA  Sanofi, Bridgewater, United States, MA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, United States, MD  

Efficacy and Safety of IL-6 Inhibitors in Neuromyelitis Optica Spectrum Disorder (NMOSD): A Network Meta-analysis

Author:Raj, Rishu   Sharma, Arkansh   Datta, Abhigyan   Kaur, Gurleen   Duggal, Ashish   Nithyanandam, Allimuthu   Suresh, Vinay   

Session Name:P7: Autoimmune Neurology: NMOSD/MOGAD 6  

Topic:Autoimmune Neurology  

Program Number:P7.005  

Author Institution:Atal Bihari Vajpayee Institute of Medical Sciences and Dr. RML Hospital, New Delhi, India, Ghaziabad, India  Government Medical College, Omandurar, Chennai, Tamil Nadu, India, Chennai, India  University of Minnesota, USA, Minneapolis, MN  All India Institute Of Medical Sciences, Patna, India , Abohar, India  Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, New Delhi, India  Department of Neurology, Tamil Nadu Government Multi-Super Speciality Hospital, Omandurar Government Estate, Chennai, India, Chennai, India  University of Oxford, United Kingdom, United Kingdom